Hashiguchi Takuyu, Arakawa Shingo, Takahashi Shogo, Gonzalez Frank J, Sueyoshi Tatsuya, Negishi Masahiko
Pharmacogenetics Section (T.H., S.A., T.S., M.N.), Reproductive and Developmental Biology Laboratory, National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, North Carolina 27709; and Laboratory of Metabolism (S.T., F.J.G.), Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892.
Mol Endocrinol. 2016 Oct;30(10):1070-1080. doi: 10.1210/me.2016-1105. Epub 2016 Aug 29.
Comparison of 11 human nuclear receptor amino acid sequences revealed a conserved phosphorylation motif within their DNA-binding domains as an intramolecular signal that regulates proteolytic degradation. Nuclear receptors use this signal to either degrade or proscribe degradation through either the proteasome or nonproteasome pathways. A phosphomimetic farnesoid X receptor (FXR) S154D mutant neither bound to nor trans-activated an FXR-response element-driven reporter gene and was rapidly degraded in COS-1 cells. Ectopically expressed FXR had increased Ser154 phosphorylation in COS-1 cells after ligand treatment, and knock-down of the nuclear vaccinia-related kinase 1 (VRK1) greatly reduced this phosphorylation. FXR was phosphorylated at Ser154 in the nucleus of centrilobular hepatocytes only in ligand-treated mice. Thus, FXR Ser154 phosphorylation is a rheostat for activation and subsequent degradation that controls receptor levels and activity.
对11种人类核受体氨基酸序列的比较揭示,在其DNA结合域内存在一个保守的磷酸化基序,作为一种调节蛋白水解降解的分子内信号。核受体利用该信号通过蛋白酶体或非蛋白酶体途径进行降解或抑制降解。一种模拟磷酸化的法尼酯X受体(FXR)S154D突变体既不与FXR反应元件驱动的报告基因结合,也不激活该报告基因,并且在COS-1细胞中迅速降解。异位表达的FXR在配体处理后的COS-1细胞中Ser154磷酸化增加,而核痘苗相关激酶1(VRK1)的敲低大大降低了这种磷酸化。仅在经配体处理的小鼠的小叶中央肝细胞的细胞核中,FXR在Ser154处被磷酸化。因此,FXR Ser154磷酸化是一种用于激活及随后降解的变阻器,可控制受体水平和活性。